WASHINGTON ― Adding the PD-1 inhibitor pembrolizumab to the established combination of dabrafenib and trametinib (DT) significantly improves survival outcomes in BRAF V600E-mutated anaplastic thyroid ...

Please provide your email address to receive an email when new articles are posted on . “Anaplastic thyroid cancer patients with prior histories of other cancers have similar survival outcomes as ...

Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Anaplastic thyroid cancer is a rare thyroid malignancy; disease-specific mortality ...

CHAPEL HILL, N.C. (WTVD) -- UNC Lineberger is leading a new trial into a possible treatment option for anaplastic thyroid cancer. "This is the one cancer diagnosis that I personally dread having to ...

Please provide your email address to receive an email when new articles are posted on . The triplet combination of vemurafenib/cobimetinib/atezolizumab showed ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the anaplastic thyroid cancer market. The report includes a detailed analysis of the pipeline molecules under ...

HOUSTON ― Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival ...

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial Patients who underwent ...

Image Caption: Key signaling pathways in anaplastic thyroid cancer. Different pathways are labeled in different colors, and different components in the same pathway are portrayed in the same color.